Raymond James & Associates »

Intra Cellular Therapies shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 159k 73.17
2024-06-30 $11M 155k 68.49
2024-03-31 $11M 156k 69.20
2023-12-31 $9.9M 139k 71.62
2023-09-30 $7.8M 149k 52.09
2023-06-30 $9.1M 144k 63.32
2023-03-31 $7.7M 143k 54.15
2022-12-31 $7.7M 145k 52.92
2022-09-30 $7.6M 164k 46.53
2022-06-30 $8.5M 150k 57.08
2022-03-31 $9.1M 149k 61.19
2021-12-31 $7.3M 140k 52.34
2021-09-30 $5.0M 134k 37.28
2021-06-30 $4.6M 114k 40.82
2021-03-31 $2.8M 83k 33.93
2020-12-31 $2.6M 82k 31.80
2020-09-30 $4.0M 156k 25.66
2020-06-30 $4.2M 165k 25.67
2020-03-31 $2.0M 133k 15.37
2019-12-31 $4.6M 135k 34.31
2019-09-30 $676k 91k 7.47
2019-06-30 $1.1M 85k 12.98
2019-03-31 $836k 69k 12.18
2018-12-31 $378k 33k 11.39
2018-09-30 $1.5M 71k 21.69
2018-06-30 $1.1M 64k 17.68
2018-03-31 $1.0M 48k 21.04
2017-12-31 $237k 16k 14.50